

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal epithelial cell development (GO:0060576) | 9.65838450 |
| 2 | intestinal cholesterol absorption (GO:0030299) | 9.50023049 |
| 3 | intestinal absorption (GO:0050892) | 8.63623786 |
| 4 | low-density lipoprotein particle remodeling (GO:0034374) | 8.33065980 |
| 5 | lung secretory cell differentiation (GO:0061140) | 8.29923978 |
| 6 | digestion (GO:0007586) | 7.67573829 |
| 7 | regulation of guanylate cyclase activity (GO:0031282) | 7.46433000 |
| 8 | bile acid and bile salt transport (GO:0015721) | 7.35444795 |
| 9 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.23019872 |
| 10 | maintenance of gastrointestinal epithelium (GO:0030277) | 6.21661096 |
| 11 | sulfation (GO:0051923) | 6.07431323 |
| 12 | hepatocyte apoptotic process (GO:0097284) | 6.00238996 |
| 13 | glandular epithelial cell differentiation (GO:0002067) | 5.94455038 |
| 14 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 5.92398274 |
| 15 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 5.87212837 |
| 16 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.69691071 |
| 17 | epoxygenase P450 pathway (GO:0019373) | 5.67592878 |
| 18 | NADH metabolic process (GO:0006734) | 5.65635362 |
| 19 | cellular glucuronidation (GO:0052695) | 5.62723007 |
| 20 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 5.62694099 |
| 21 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 5.53180701 |
| 22 | sulfate transmembrane transport (GO:1902358) | 5.52834254 |
| 23 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 5.51011088 |
| 24 | glucuronate metabolic process (GO:0019585) | 5.49166266 |
| 25 | uronic acid metabolic process (GO:0006063) | 5.49166266 |
| 26 | digestive system process (GO:0022600) | 5.44825011 |
| 27 | lipoprotein transport (GO:0042953) | 5.32209627 |
| 28 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.24963697 |
| 29 | endocrine process (GO:0050886) | 5.24963697 |
| 30 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.24963697 |
| 31 | proline biosynthetic process (GO:0006561) | 5.15206481 |
| 32 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.13959194 |
| 33 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 5.12125576 |
| 34 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 5.04108882 |
| 35 | positive regulation of respiratory burst (GO:0060267) | 4.85133333 |
| 36 | renal system process involved in regulation of blood volume (GO:0001977) | 4.83663524 |
| 37 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.75712743 |
| 38 | regulation of systemic arterial blood pressure (GO:0003073) | 4.63304007 |
| 39 | regulation of cGMP biosynthetic process (GO:0030826) | 4.63092005 |
| 40 | epithelial structure maintenance (GO:0010669) | 4.59130444 |
| 41 | O-glycan processing (GO:0016266) | 4.54884521 |
| 42 | sulfate transport (GO:0008272) | 4.51582022 |
| 43 | galactose catabolic process (GO:0019388) | 4.50817697 |
| 44 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 4.42961703 |
| 45 | positive regulation of pseudopodium assembly (GO:0031274) | 4.41278169 |
| 46 | phosphatidylserine metabolic process (GO:0006658) | 4.41220300 |
| 47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.37458979 |
| 48 | protein-lipid complex remodeling (GO:0034368) | 4.37458979 |
| 49 | macromolecular complex remodeling (GO:0034367) | 4.37458979 |
| 50 | hormone catabolic process (GO:0042447) | 4.36984319 |
| 51 | regulation of vitamin metabolic process (GO:0030656) | 4.30484726 |
| 52 | drug metabolic process (GO:0017144) | 4.29982860 |
| 53 | exocrine pancreas development (GO:0031017) | 4.27880427 |
| 54 | transcytosis (GO:0045056) | 4.23564560 |
| 55 | primary alcohol catabolic process (GO:0034310) | 4.23143265 |
| 56 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.22780777 |
| 57 | galactose metabolic process (GO:0006012) | 4.19438359 |
| 58 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 4.19260414 |
| 59 | ethanol metabolic process (GO:0006067) | 4.16619177 |
| 60 | negative regulation of cell fate commitment (GO:0010454) | 4.15095414 |
| 61 | regulation of norepinephrine secretion (GO:0014061) | 4.11714912 |
| 62 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.11486933 |
| 63 | GDP-mannose metabolic process (GO:0019673) | 4.08208832 |
| 64 | antibacterial humoral response (GO:0019731) | 4.06871005 |
| 65 | fructose metabolic process (GO:0006000) | 4.02593160 |
| 66 | protein retention in ER lumen (GO:0006621) | 3.97757179 |
| 67 | urea cycle (GO:0000050) | 3.96798744 |
| 68 | regulation of pseudopodium assembly (GO:0031272) | 3.94789494 |
| 69 | antimicrobial humoral response (GO:0019730) | 3.91514127 |
| 70 | bile acid metabolic process (GO:0008206) | 3.89423959 |
| 71 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.89153457 |
| 72 | oligosaccharide biosynthetic process (GO:0009312) | 3.87689628 |
| 73 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.85938141 |
| 74 | regulation of cGMP metabolic process (GO:0030823) | 3.85140611 |
| 75 | urea metabolic process (GO:0019627) | 3.78803513 |
| 76 | cysteine metabolic process (GO:0006534) | 3.78497166 |
| 77 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.76239914 |
| 78 | regulation of triglyceride catabolic process (GO:0010896) | 3.73155428 |
| 79 | glomerular filtration (GO:0003094) | 3.69583890 |
| 80 | ethanol oxidation (GO:0006069) | 3.67535874 |
| 81 | adhesion of symbiont to host cell (GO:0044650) | 3.66802616 |
| 82 | virion attachment to host cell (GO:0019062) | 3.66802616 |
| 83 | mucosal immune response (GO:0002385) | 3.66619071 |
| 84 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.64686971 |
| 85 | lung epithelial cell differentiation (GO:0060487) | 3.63342501 |
| 86 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.62813288 |
| 87 | lung cell differentiation (GO:0060479) | 3.62226826 |
| 88 | sulfur amino acid catabolic process (GO:0000098) | 3.62206201 |
| 89 | regulation of respiratory burst (GO:0060263) | 3.60860925 |
| 90 | alditol phosphate metabolic process (GO:0052646) | 3.59487955 |
| 91 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.58286630 |
| 92 | regulation of bile acid biosynthetic process (GO:0070857) | 3.56599651 |
| 93 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.54701121 |
| 94 | plasma lipoprotein particle organization (GO:0071827) | 3.54643573 |
| 95 | regulation of cholesterol homeostasis (GO:2000188) | 3.52737487 |
| 96 | cobalamin metabolic process (GO:0009235) | 3.52311722 |
| 97 | sulfur compound transport (GO:0072348) | 3.52253041 |
| 98 | proline metabolic process (GO:0006560) | 3.51978163 |
| 99 | protein-lipid complex subunit organization (GO:0071825) | 3.51662207 |
| 100 | glycosphingolipid catabolic process (GO:0046479) | 3.51428676 |
| 101 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.51087009 |
| 102 | glycolipid catabolic process (GO:0019377) | 3.49404839 |
| 103 | peptide hormone processing (GO:0016486) | 3.48999358 |
| 104 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.48878139 |
| 105 | nitrogen cycle metabolic process (GO:0071941) | 3.46376001 |
| 106 | regulation of keratinocyte proliferation (GO:0010837) | 3.45685256 |
| 107 | organ or tissue specific immune response (GO:0002251) | 3.45676478 |
| 108 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.42587911 |
| 109 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.41750823 |
| 110 | glucocorticoid biosynthetic process (GO:0006704) | 3.41297783 |
| 111 | plasma lipoprotein particle assembly (GO:0034377) | 3.40019521 |
| 112 | cGMP-mediated signaling (GO:0019934) | 3.39881493 |
| 113 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 3.39602411 |
| 114 | vitamin transmembrane transport (GO:0035461) | 3.39392114 |
| 115 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.39341882 |
| 116 | thrombin receptor signaling pathway (GO:0070493) | 3.39340491 |
| 117 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.38934020 |
| 118 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.38216925 |
| 119 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.38216925 |
| 120 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.38108950 |
| 121 | drug transport (GO:0015893) | 3.38056791 |
| 122 | drug transmembrane transport (GO:0006855) | 3.37418933 |
| 123 | renal filtration (GO:0097205) | 3.34360648 |
| 124 | drug catabolic process (GO:0042737) | 3.30973615 |
| 125 | positive regulation of lipid catabolic process (GO:0050996) | 3.30654231 |
| 126 | sphingomyelin metabolic process (GO:0006684) | 3.30161745 |
| 127 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.29691075 |
| 128 | regulation of viral entry into host cell (GO:0046596) | 3.22619937 |
| 129 | alkaloid metabolic process (GO:0009820) | 3.21031154 |
| 130 | arginine metabolic process (GO:0006525) | 3.20692038 |
| 131 | leukotriene biosynthetic process (GO:0019370) | 3.20306480 |
| 132 | cGMP biosynthetic process (GO:0006182) | 3.18299229 |
| 133 | glycosylceramide metabolic process (GO:0006677) | 3.17615592 |
| 134 | N-acetylglucosamine metabolic process (GO:0006044) | 3.16076700 |
| 135 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.15490334 |
| 136 | nucleotide-sugar metabolic process (GO:0009225) | 3.14626786 |
| 137 | phospholipid efflux (GO:0033700) | 3.14166428 |
| 138 | diacylglycerol metabolic process (GO:0046339) | 3.13165484 |
| 139 | sodium ion homeostasis (GO:0055078) | 3.11782983 |
| 140 | protein-lipid complex assembly (GO:0065005) | 3.10840489 |
| 141 | endocrine pancreas development (GO:0031018) | 3.10820333 |
| 142 | exogenous drug catabolic process (GO:0042738) | 3.10461230 |
| 143 | adhesion of symbiont to host (GO:0044406) | 3.09938603 |
| 144 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.09747774 |
| 145 | regulation of cellular extravasation (GO:0002691) | 3.09358885 |
| 146 | auditory receptor cell differentiation (GO:0042491) | 3.08643264 |
| 147 | peptide catabolic process (GO:0043171) | 3.08308798 |
| 148 | phosphatidic acid metabolic process (GO:0046473) | 3.07764378 |
| 149 | phosphatidic acid biosynthetic process (GO:0006654) | 3.07764378 |
| 150 | angiotensin maturation (GO:0002003) | 3.07269783 |
| 151 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.06677524 |
| 152 | ATP synthesis coupled proton transport (GO:0015986) | 3.06677524 |
| 153 | lipoprotein metabolic process (GO:0042157) | 3.06560554 |
| 154 | glycerol metabolic process (GO:0006071) | 3.06478632 |
| 155 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.06413329 |
| 156 | signal peptide processing (GO:0006465) | 3.03981772 |
| 157 | regulation of protein glycosylation (GO:0060049) | 3.03932749 |
| 158 | regulation of actin nucleation (GO:0051125) | 2.98322625 |
| 159 | vitamin transport (GO:0051180) | 2.98191488 |
| 160 | nucleotide transmembrane transport (GO:1901679) | 2.97950409 |
| 161 | actin filament depolymerization (GO:0030042) | 2.97772164 |
| 162 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.93102091 |
| 163 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.90743343 |
| 164 | negative regulation of digestive system process (GO:0060457) | 2.90711249 |
| 165 | protein O-linked glycosylation (GO:0006493) | 2.89964111 |
| 166 | homocysteine metabolic process (GO:0050667) | 2.89476507 |
| 167 | leukocyte tethering or rolling (GO:0050901) | 2.86768891 |
| 168 | positive regulation of cell fate commitment (GO:0010455) | 2.85833964 |
| 169 | glucose 6-phosphate metabolic process (GO:0051156) | 2.85487748 |
| 170 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.84007041 |
| 171 | negative regulation of epidermis development (GO:0045683) | 2.78195185 |
| 172 | cardiac conduction (GO:0061337) | 2.77459387 |
| 173 | vitamin A metabolic process (GO:0006776) | 2.75822556 |
| 174 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.75145817 |
| 175 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.73789820 |
| 176 | phosphatidylglycerol metabolic process (GO:0046471) | 2.73544560 |
| 177 | amino sugar metabolic process (GO:0006040) | 2.72867318 |
| 178 | flavonoid metabolic process (GO:0009812) | 2.72768272 |
| 179 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.72442002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.39975692 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.62583209 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.57643248 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 4.24001558 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.84365907 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.64942905 |
| 7 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.30873293 |
| 8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.27178511 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.23886602 |
| 10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.02327484 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.94361692 |
| 12 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.93596540 |
| 13 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 2.91597229 |
| 14 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.82842549 |
| 15 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.77755214 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.65235275 |
| 17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.61356689 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.54743102 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.20626007 |
| 20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.17757015 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.99770913 |
| 22 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.96365758 |
| 23 | * STAT1_20625510_ChIP-Seq_HELA_Human | 1.93622547 |
| 24 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.90688247 |
| 25 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.88750458 |
| 26 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.83873804 |
| 27 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.83009305 |
| 28 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.69379860 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68139598 |
| 30 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.67349048 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.66735857 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.66198093 |
| 33 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.65253190 |
| 34 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.64471279 |
| 35 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.55944422 |
| 36 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.55019145 |
| 37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.54121629 |
| 38 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.53132326 |
| 39 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.52707510 |
| 40 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.51380586 |
| 41 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.49705729 |
| 42 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.49490907 |
| 43 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.48297629 |
| 44 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.42462879 |
| 45 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.41618494 |
| 46 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.38047103 |
| 47 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.35789010 |
| 48 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34017809 |
| 49 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.33598910 |
| 50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.33091588 |
| 51 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.31538252 |
| 52 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30976791 |
| 53 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29854486 |
| 54 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.28610868 |
| 55 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.25836282 |
| 56 | ATF3_27146783_Chip-Seq_COLON_Human | 1.22822497 |
| 57 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.22073739 |
| 58 | GATA2_19941826_ChIP-Seq_K562_Human | 1.21501661 |
| 59 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21194671 |
| 60 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.21123494 |
| 61 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.19277805 |
| 62 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18807872 |
| 63 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.16444150 |
| 64 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.15391537 |
| 65 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.13665112 |
| 66 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12580448 |
| 67 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.11711221 |
| 68 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10955682 |
| 69 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.10708159 |
| 70 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.10213562 |
| 71 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09747986 |
| 72 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.09161634 |
| 73 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.09096340 |
| 74 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08755477 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08646250 |
| 76 | SA1_27219007_Chip-Seq_Bcells_Human | 1.08254518 |
| 77 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08093783 |
| 78 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.07982593 |
| 79 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 1.07778723 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06567195 |
| 81 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.06346299 |
| 82 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06004151 |
| 83 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.03912760 |
| 84 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.03448916 |
| 85 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02555392 |
| 86 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.01224488 |
| 87 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00357538 |
| 88 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.99423232 |
| 89 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.99405912 |
| 90 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98803968 |
| 91 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98170976 |
| 92 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97558718 |
| 93 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.96989839 |
| 94 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.96827952 |
| 95 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96348058 |
| 96 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.96135440 |
| 97 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.95202716 |
| 98 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.95198683 |
| 99 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.94935509 |
| 100 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93967713 |
| 101 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.93094214 |
| 102 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.92918779 |
| 103 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.92698863 |
| 104 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91453735 |
| 105 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.91077188 |
| 106 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.90463334 |
| 107 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89528299 |
| 108 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.89422122 |
| 109 | * PHF8_20622854_ChIP-Seq_HELA_Human | 0.88961223 |
| 110 | P68_20966046_ChIP-Seq_HELA_Human | 0.88954293 |
| 111 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.88329534 |
| 112 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.88323166 |
| 113 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.87912759 |
| 114 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.87231700 |
| 115 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.87157157 |
| 116 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85091717 |
| 117 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84827801 |
| 118 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84605984 |
| 119 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84472064 |
| 120 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.84253034 |
| 121 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84127919 |
| 122 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.83832490 |
| 123 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.83828521 |
| 124 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.83098185 |
| 125 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.82318795 |
| 126 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.82109776 |
| 127 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.81768695 |
| 128 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.80951518 |
| 129 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.77807140 |
| 130 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.76995019 |
| 131 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75260615 |
| 132 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.74517541 |
| 133 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.74212097 |
| 134 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.73870351 |
| 135 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.72018941 |
| 136 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.71719229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001666_abnormal_nutrient_absorption | 6.84450541 |
| 2 | MP0003868_abnormal_feces_composition | 5.29196507 |
| 3 | MP0005360_urolithiasis | 5.20729933 |
| 4 | MP0004264_abnormal_extraembryonic_tissu | 4.35700859 |
| 5 | MP0005365_abnormal_bile_salt | 3.92319763 |
| 6 | MP0001873_stomach_inflammation | 3.71352955 |
| 7 | MP0010155_abnormal_intestine_physiology | 3.69916058 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.60463760 |
| 9 | MP0000490_abnormal_crypts_of | 3.47738901 |
| 10 | MP0003866_abnormal_defecation | 3.36176480 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 3.14984702 |
| 12 | MP0010234_abnormal_vibrissa_follicle | 3.10193322 |
| 13 | MP0001663_abnormal_digestive_system | 2.92384210 |
| 14 | MP0001664_abnormal_digestion | 2.75442491 |
| 15 | MP0005083_abnormal_biliary_tract | 2.67330670 |
| 16 | MP0000462_abnormal_digestive_system | 2.59827992 |
| 17 | MP0005381_digestive/alimentary_phenotyp | 2.44369557 |
| 18 | MP0003252_abnormal_bile_duct | 2.42301722 |
| 19 | MP0000477_abnormal_intestine_morphology | 2.35835191 |
| 20 | MP0005165_increased_susceptibility_to | 2.25221965 |
| 21 | MP0002277_abnormal_respiratory_mucosa | 2.23734347 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 2.16178042 |
| 23 | MP0003705_abnormal_hypodermis_morpholog | 2.08239909 |
| 24 | MP0005409_darkened_coat_color | 1.94956887 |
| 25 | MP0005084_abnormal_gallbladder_morpholo | 1.93381385 |
| 26 | MP0005666_abnormal_adipose_tissue | 1.92342949 |
| 27 | MP0002876_abnormal_thyroid_physiology | 1.79605612 |
| 28 | MP0008004_abnormal_stomach_pH | 1.73256399 |
| 29 | MP0003183_abnormal_peptide_metabolism | 1.72103034 |
| 30 | MP0005670_abnormal_white_adipose | 1.67311191 |
| 31 | MP0000465_gastrointestinal_hemorrhage | 1.66139984 |
| 32 | MP0003806_abnormal_nucleotide_metabolis | 1.65069796 |
| 33 | MP0000537_abnormal_urethra_morphology | 1.64265635 |
| 34 | MP0005220_abnormal_exocrine_pancreas | 1.63719705 |
| 35 | MP0005448_abnormal_energy_balance | 1.58245573 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.48969813 |
| 37 | MP0010352_gastrointestinal_tract_polyps | 1.46700977 |
| 38 | MP0001764_abnormal_homeostasis | 1.44813528 |
| 39 | MP0005451_abnormal_body_composition | 1.43173010 |
| 40 | MP0009780_abnormal_chondrocyte_physiolo | 1.41217862 |
| 41 | MP0004019_abnormal_vitamin_homeostasis | 1.39554892 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.32515100 |
| 43 | MP0004782_abnormal_surfactant_physiolog | 1.30752579 |
| 44 | MP0001188_hyperpigmentation | 1.26847223 |
| 45 | MP0010329_abnormal_lipoprotein_level | 1.26531696 |
| 46 | MP0006054_spinal_hemorrhage | 1.22017376 |
| 47 | MP0002138_abnormal_hepatobiliary_system | 1.21943331 |
| 48 | MP0005375_adipose_tissue_phenotype | 1.20309049 |
| 49 | MP0002118_abnormal_lipid_homeostasis | 1.16722622 |
| 50 | MP0000470_abnormal_stomach_morphology | 1.13014228 |
| 51 | MP0000230_abnormal_systemic_arterial | 1.12658684 |
| 52 | MP0004858_abnormal_nervous_system | 1.09842696 |
| 53 | MP0002822_catalepsy | 1.09417211 |
| 54 | MP0009643_abnormal_urine_homeostasis | 1.09130972 |
| 55 | MP0003878_abnormal_ear_physiology | 1.06579984 |
| 56 | MP0005377_hearing/vestibular/ear_phenot | 1.06579984 |
| 57 | MP0001756_abnormal_urination | 1.03628923 |
| 58 | MP0005332_abnormal_amino_acid | 1.03539712 |
| 59 | MP0002693_abnormal_pancreas_physiology | 1.01894954 |
| 60 | MP0009840_abnormal_foam_cell | 0.98181385 |
| 61 | MP0001845_abnormal_inflammatory_respons | 0.97228917 |
| 62 | MP0001849_ear_inflammation | 0.96794558 |
| 63 | MP0003879_abnormal_hair_cell | 0.93157955 |
| 64 | MP0004185_abnormal_adipocyte_glucose | 0.87533660 |
| 65 | MP0002796_impaired_skin_barrier | 0.84139821 |
| 66 | MP0002166_altered_tumor_susceptibility | 0.83801563 |
| 67 | MP0009785_altered_susceptibility_to | 0.82239069 |
| 68 | MP0002971_abnormal_brown_adipose | 0.80606000 |
| 69 | MP0002009_preneoplasia | 0.78052103 |
| 70 | MP0001944_abnormal_pancreas_morphology | 0.77112522 |
| 71 | MP0003724_increased_susceptibility_to | 0.76197214 |
| 72 | MP0003718_maternal_effect | 0.75676930 |
| 73 | MP0008872_abnormal_physiological_respon | 0.75412465 |
| 74 | MP0000538_abnormal_urinary_bladder | 0.74576508 |
| 75 | MP0005334_abnormal_fat_pad | 0.72522923 |
| 76 | MP0001765_abnormal_ion_homeostasis | 0.71547300 |
| 77 | MP0005535_abnormal_body_temperature | 0.71317469 |
| 78 | MP0005166_decreased_susceptibility_to | 0.70820266 |
| 79 | MP0000609_abnormal_liver_physiology | 0.69928300 |
| 80 | MP0002006_tumorigenesis | 0.68264485 |
| 81 | MP0009115_abnormal_fat_cell | 0.66319729 |
| 82 | MP0008469_abnormal_protein_level | 0.64514516 |
| 83 | MP0005025_abnormal_response_to | 0.63832120 |
| 84 | MP0006082_CNS_inflammation | 0.63791389 |
| 85 | MP0003959_abnormal_lean_body | 0.63318370 |
| 86 | MP0003303_peritoneal_inflammation | 0.61704553 |
| 87 | MP0000604_amyloidosis | 0.61490438 |
| 88 | MP0005310_abnormal_salivary_gland | 0.59294203 |
| 89 | MP0003638_abnormal_response/metabolism_ | 0.58864717 |
| 90 | MP0003329_amyloid_beta_deposits | 0.58337951 |
| 91 | MP0002896_abnormal_bone_mineralization | 0.58149033 |
| 92 | MP0010678_abnormal_skin_adnexa | 0.57560041 |
| 93 | MP0005319_abnormal_enzyme/_coenzyme | 0.57327274 |
| 94 | MP0002089_abnormal_postnatal_growth/wei | 0.57247798 |
| 95 | MP0003123_paternal_imprinting | 0.57030839 |
| 96 | MP0001485_abnormal_pinna_reflex | 0.56388524 |
| 97 | MP0005387_immune_system_phenotype | 0.55871524 |
| 98 | MP0001790_abnormal_immune_system | 0.55871524 |
| 99 | MP0003283_abnormal_digestive_organ | 0.54485821 |
| 100 | MP0010386_abnormal_urinary_bladder | 0.52924428 |
| 101 | MP0000249_abnormal_blood_vessel | 0.51939288 |
| 102 | MP0000566_synostosis | 0.51555201 |
| 103 | MP0003953_abnormal_hormone_level | 0.50314227 |
| 104 | MP0005058_abnormal_lysosome_morphology | 0.50101851 |
| 105 | MP0004947_skin_inflammation | 0.49555946 |
| 106 | MP0005636_abnormal_mineral_homeostasis | 0.48328056 |
| 107 | MP0002098_abnormal_vibrissa_morphology | 0.48166449 |
| 108 | MP0004043_abnormal_pH_regulation | 0.47961414 |
| 109 | MP0003436_decreased_susceptibility_to | 0.46957310 |
| 110 | MP0002078_abnormal_glucose_homeostasis | 0.46307167 |
| 111 | MP0000003_abnormal_adipose_tissue | 0.45711039 |
| 112 | MP0009642_abnormal_blood_homeostasis | 0.44759802 |
| 113 | MP0000467_abnormal_esophagus_morphology | 0.44236154 |
| 114 | MP0001501_abnormal_sleep_pattern | 0.43080437 |
| 115 | MP0002148_abnormal_hypersensitivity_rea | 0.42562908 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.41567259 |
| 117 | MP0005167_abnormal_blood-brain_barrier | 0.41344359 |
| 118 | MP0003453_abnormal_keratinocyte_physiol | 0.40706807 |
| 119 | MP0003828_pulmonary_edema | 0.40534817 |
| 120 | MP0004484_altered_response_of | 0.39608828 |
| 121 | MP0005076_abnormal_cell_differentiation | 0.38123833 |
| 122 | MP0000598_abnormal_liver_morphology | 0.37706458 |
| 123 | MP0000678_abnormal_parathyroid_gland | 0.37314515 |
| 124 | MP0004147_increased_porphyrin_level | 0.36156531 |
| 125 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.35934814 |
| 126 | MP0002136_abnormal_kidney_physiology | 0.35812739 |
| 127 | MP0004270_analgesia | 0.35376439 |
| 128 | MP0005501_abnormal_skin_physiology | 0.35022643 |
| 129 | MP0009379_abnormal_foot_pigmentation | 0.34630165 |
| 130 | MP0001216_abnormal_epidermal_layer | 0.34275981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Micronodular cirrhosis (HP:0001413) | 5.54476278 |
| 2 | Abnormality of renin-angiotensin system (HP:0000847) | 5.45546690 |
| 3 | Abdominal distention (HP:0003270) | 5.00923867 |
| 4 | Ileus (HP:0002595) | 4.97108488 |
| 5 | Right ventricular cardiomyopathy (HP:0011663) | 4.75700770 |
| 6 | Alkalosis (HP:0001948) | 4.63895563 |
| 7 | Late onset (HP:0003584) | 4.43120213 |
| 8 | Fat malabsorption (HP:0002630) | 4.35485129 |
| 9 | Ketoacidosis (HP:0001993) | 4.04301893 |
| 10 | Ventricular fibrillation (HP:0001663) | 4.04129537 |
| 11 | Esophageal varix (HP:0002040) | 4.03363891 |
| 12 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.97430301 |
| 13 | Congenital sensorineural hearing impairment (HP:0008527) | 3.96308411 |
| 14 | Syncope (HP:0001279) | 3.85888692 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.77563011 |
| 16 | Abnormality of vitamin B metabolism (HP:0004340) | 3.74684256 |
| 17 | Hyperaldosteronism (HP:0000859) | 3.72151948 |
| 18 | Abnormality of chloride homeostasis (HP:0011422) | 3.67077777 |
| 19 | Steatorrhea (HP:0002570) | 3.53954733 |
| 20 | Prolonged QT interval (HP:0001657) | 3.49884650 |
| 21 | Widely patent fontanelles and sutures (HP:0004492) | 3.44057544 |
| 22 | Acanthocytosis (HP:0001927) | 3.41883623 |
| 23 | Bundle branch block (HP:0011710) | 3.28077151 |
| 24 | Exocrine pancreatic insufficiency (HP:0001738) | 3.23301684 |
| 25 | Abnormality of vitamin metabolism (HP:0100508) | 3.20091109 |
| 26 | Systemic lupus erythematosus (HP:0002725) | 3.17966660 |
| 27 | Hyperparathyroidism (HP:0000843) | 3.16825740 |
| 28 | Malnutrition (HP:0004395) | 3.12648442 |
| 29 | Hypokalemia (HP:0002900) | 2.99252531 |
| 30 | Pigmentary retinal degeneration (HP:0001146) | 2.97624159 |
| 31 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.93846422 |
| 32 | Nausea (HP:0002018) | 2.93439826 |
| 33 | Chronic diarrhea (HP:0002028) | 2.85295822 |
| 34 | Hypercortisolism (HP:0001578) | 2.83696733 |
| 35 | Ketosis (HP:0001946) | 2.82612002 |
| 36 | Hypoglycemic coma (HP:0001325) | 2.82561940 |
| 37 | Conjugated hyperbilirubinemia (HP:0002908) | 2.81463801 |
| 38 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.79848192 |
| 39 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.79848192 |
| 40 | Palpitations (HP:0001962) | 2.79128445 |
| 41 | Hyponatremia (HP:0002902) | 2.78990837 |
| 42 | Glycosuria (HP:0003076) | 2.76899304 |
| 43 | Abnormality of urine glucose concentration (HP:0011016) | 2.76899304 |
| 44 | Gout (HP:0001997) | 2.75775795 |
| 45 | Hemorrhage of the eye (HP:0011885) | 2.75388698 |
| 46 | Abnormality of potassium homeostasis (HP:0011042) | 2.70766367 |
| 47 | Intrahepatic cholestasis (HP:0001406) | 2.69446373 |
| 48 | Abnormal foot bone ossification (HP:0010675) | 2.67212866 |
| 49 | Posterior subcapsular cataract (HP:0007787) | 2.66983112 |
| 50 | Woolly hair (HP:0002224) | 2.64471969 |
| 51 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.58808181 |
| 52 | Conjunctival hamartoma (HP:0100780) | 2.58707002 |
| 53 | Insulin resistance (HP:0000855) | 2.56252127 |
| 54 | Nephrolithiasis (HP:0000787) | 2.55221493 |
| 55 | Increased muscle lipid content (HP:0009058) | 2.53793498 |
| 56 | Generalized aminoaciduria (HP:0002909) | 2.53404120 |
| 57 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.50383479 |
| 58 | Abnormality of glycine metabolism (HP:0010895) | 2.50383479 |
| 59 | Wide cranial sutures (HP:0010537) | 2.49388268 |
| 60 | Flattened epiphyses (HP:0003071) | 2.48521878 |
| 61 | Eczematoid dermatitis (HP:0000976) | 2.48364281 |
| 62 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.47593302 |
| 63 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.40287497 |
| 64 | Neonatal short-limb short stature (HP:0008921) | 2.39501700 |
| 65 | Hyperammonemia (HP:0001987) | 2.39009018 |
| 66 | Flat capital femoral epiphysis (HP:0003370) | 2.36863671 |
| 67 | Renal tubular acidosis (HP:0001947) | 2.34667263 |
| 68 | Protuberant abdomen (HP:0001538) | 2.34625769 |
| 69 | Pancreatitis (HP:0001733) | 2.34126154 |
| 70 | Increased intramyocellular lipid droplets (HP:0012240) | 2.33395237 |
| 71 | Dicarboxylic aciduria (HP:0003215) | 2.31952789 |
| 72 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.31952789 |
| 73 | Hypotension (HP:0002615) | 2.31601724 |
| 74 | Thin bony cortex (HP:0002753) | 2.31340947 |
| 75 | Bone cyst (HP:0012062) | 2.30067928 |
| 76 | Focal segmental glomerulosclerosis (HP:0000097) | 2.27756913 |
| 77 | Hypolipoproteinemia (HP:0010981) | 2.26612011 |
| 78 | Acute encephalopathy (HP:0006846) | 2.26224776 |
| 79 | Abnormality of purine metabolism (HP:0004352) | 2.23227333 |
| 80 | Lethargy (HP:0001254) | 2.22292511 |
| 81 | Hypobetalipoproteinemia (HP:0003563) | 2.20845847 |
| 82 | Dehydration (HP:0001944) | 2.20226667 |
| 83 | Symptomatic seizures (HP:0011145) | 2.18618994 |
| 84 | Reduced antithrombin III activity (HP:0001976) | 2.17848123 |
| 85 | Enlarged epiphyses (HP:0010580) | 2.17742701 |
| 86 | Villous atrophy (HP:0011473) | 2.17428188 |
| 87 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.17428188 |
| 88 | Abnormality of proline metabolism (HP:0010907) | 2.16418208 |
| 89 | Hydroxyprolinuria (HP:0003080) | 2.16418208 |
| 90 | Confusion (HP:0001289) | 2.16139900 |
| 91 | Hypophosphatemia (HP:0002148) | 2.15407313 |
| 92 | Metabolic acidosis (HP:0001942) | 2.15226109 |
| 93 | Abnormal EKG (HP:0003115) | 2.14943932 |
| 94 | Hyperactive renin-angiotensin system (HP:0000841) | 2.14005921 |
| 95 | Hepatic necrosis (HP:0002605) | 2.13779878 |
| 96 | Pili torti (HP:0003777) | 2.13318710 |
| 97 | Hyperglycinuria (HP:0003108) | 2.10798281 |
| 98 | Xanthomatosis (HP:0000991) | 2.10592829 |
| 99 | Cerebral palsy (HP:0100021) | 2.09376768 |
| 100 | Visceral angiomatosis (HP:0100761) | 2.09309753 |
| 101 | Abnormality of the intrinsic pathway (HP:0010989) | 2.07781895 |
| 102 | Delayed epiphyseal ossification (HP:0002663) | 2.07453708 |
| 103 | Abnormality of magnesium homeostasis (HP:0004921) | 2.07402516 |
| 104 | Adrenal overactivity (HP:0002717) | 2.06673654 |
| 105 | Abnormality of sodium homeostasis (HP:0010931) | 2.06049717 |
| 106 | Neoplasm of the rectum (HP:0100743) | 2.05397394 |
| 107 | Abnormal protein glycosylation (HP:0012346) | 2.04331591 |
| 108 | Abnormal glycosylation (HP:0012345) | 2.04331591 |
| 109 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.04331591 |
| 110 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.04331591 |
| 111 | Abnormal pancreas size (HP:0012094) | 2.02248065 |
| 112 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.01246672 |
| 113 | Multiple lipomas (HP:0001012) | 2.01162925 |
| 114 | Hyperkalemia (HP:0002153) | 2.01015221 |
| 115 | Proximal tubulopathy (HP:0000114) | 2.00258248 |
| 116 | Abnormality of the gastric mucosa (HP:0004295) | 2.00013150 |
| 117 | Gastrointestinal dysmotility (HP:0002579) | 1.97902576 |
| 118 | Facial shape deformation (HP:0011334) | 1.97399683 |
| 119 | Potter facies (HP:0002009) | 1.97399683 |
| 120 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.97351128 |
| 121 | Abnormal tarsal ossification (HP:0008369) | 1.96965723 |
| 122 | Ventricular arrhythmia (HP:0004308) | 1.96054492 |
| 123 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.95768762 |
| 124 | Hyperphosphaturia (HP:0003109) | 1.95250846 |
| 125 | Megaloblastic anemia (HP:0001889) | 1.95159600 |
| 126 | Abnormal urine phosphate concentration (HP:0012599) | 1.94939033 |
| 127 | Petechiae (HP:0000967) | 1.93745397 |
| 128 | Abnormality of nucleobase metabolism (HP:0010932) | 1.93511903 |
| 129 | Rectal prolapse (HP:0002035) | 1.92906061 |
| 130 | Abnormal biliary tract morphology (HP:0012440) | 1.92255401 |
| 131 | Increased purine levels (HP:0004368) | 1.91996923 |
| 132 | Hyperuricemia (HP:0002149) | 1.91996923 |
| 133 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.91551744 |
| 134 | Abnormality of the costochondral junction (HP:0000919) | 1.88395389 |
| 135 | Hyperphosphatemia (HP:0002905) | 1.87701900 |
| 136 | Mitochondrial inheritance (HP:0001427) | 1.87352707 |
| 137 | Neoplasm of the small intestine (HP:0100833) | 1.86699668 |
| 138 | Chorioretinal atrophy (HP:0000533) | 1.86607317 |
| 139 | Decreased circulating renin level (HP:0003351) | 1.83883127 |
| 140 | Biliary tract neoplasm (HP:0100574) | 1.82859032 |
| 141 | Pheochromocytoma (HP:0002666) | 1.82021241 |
| 142 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.81805782 |
| 143 | Flat acetabular roof (HP:0003180) | 1.81670773 |
| 144 | Premature skin wrinkling (HP:0100678) | 1.81509107 |
| 145 | Hemangiomatosis (HP:0007461) | 1.81341618 |
| 146 | Myopathic facies (HP:0002058) | 1.80814523 |
| 147 | Acute necrotizing encephalopathy (HP:0006965) | 1.79939821 |
| 148 | Renal tubular dysfunction (HP:0000124) | 1.79847101 |
| 149 | Metabolic alkalosis (HP:0200114) | 1.79554192 |
| 150 | Abnormal hair laboratory examination (HP:0003328) | 1.76231874 |
| 151 | Glomerulosclerosis (HP:0000096) | 1.75603700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 8.11731745 |
| 2 | FRK | 6.34938010 |
| 3 | NME1 | 5.79096262 |
| 4 | MAP2K2 | 4.49074385 |
| 5 | EPHA2 | 4.21566253 |
| 6 | RPS6KB2 | 3.68921401 |
| 7 | ERN1 | 3.30655770 |
| 8 | MST4 | 2.67381709 |
| 9 | PTK6 | 2.48374673 |
| 10 | MST1R | 2.42365921 |
| 11 | LMTK2 | 2.37550675 |
| 12 | BCKDK | 2.22508476 |
| 13 | OXSR1 | 1.99568075 |
| 14 | TRIB3 | 1.96462015 |
| 15 | PIK3CA | 1.93087145 |
| 16 | MAP2K1 | 1.90985290 |
| 17 | MAP2K6 | 1.84694628 |
| 18 | TEC | 1.73638697 |
| 19 | BLK | 1.73083607 |
| 20 | MAP3K2 | 1.71214428 |
| 21 | TESK1 | 1.70697979 |
| 22 | TAOK1 | 1.70682842 |
| 23 | TESK2 | 1.67807333 |
| 24 | PKN2 | 1.65491865 |
| 25 | EEF2K | 1.63297398 |
| 26 | STK24 | 1.56949995 |
| 27 | PRKG2 | 1.54159590 |
| 28 | MYLK | 1.50365445 |
| 29 | MAP3K11 | 1.50186383 |
| 30 | CAMK2D | 1.46673107 |
| 31 | EPHA3 | 1.46480498 |
| 32 | TAOK3 | 1.40626029 |
| 33 | CAMK2B | 1.40101497 |
| 34 | FGFR4 | 1.36580600 |
| 35 | GRK6 | 1.30970889 |
| 36 | MAP3K12 | 1.22186409 |
| 37 | TNIK | 1.21348356 |
| 38 | KSR2 | 1.19320127 |
| 39 | EPHB2 | 1.18009500 |
| 40 | MAPKAPK3 | 1.16629229 |
| 41 | TYK2 | 1.16067829 |
| 42 | NME2 | 1.13647591 |
| 43 | CAMK2G | 1.13003880 |
| 44 | MAP3K10 | 1.08774558 |
| 45 | EPHB1 | 1.05393389 |
| 46 | PIM2 | 0.99502637 |
| 47 | CASK | 0.92721208 |
| 48 | MAP3K3 | 0.92529068 |
| 49 | PTK2 | 0.91363991 |
| 50 | PAK4 | 0.91036131 |
| 51 | NLK | 0.86739207 |
| 52 | LATS1 | 0.86656359 |
| 53 | FGFR3 | 0.82548340 |
| 54 | MAP3K7 | 0.80602565 |
| 55 | ILK | 0.80572308 |
| 56 | SCYL2 | 0.80456456 |
| 57 | MAP3K8 | 0.78639269 |
| 58 | EPHA4 | 0.76540088 |
| 59 | NUAK1 | 0.74690123 |
| 60 | MAP3K1 | 0.74333935 |
| 61 | LRRK2 | 0.71638452 |
| 62 | PRKCI | 0.69233169 |
| 63 | MET | 0.68395209 |
| 64 | FER | 0.67456559 |
| 65 | ABL2 | 0.66968929 |
| 66 | PRKACG | 0.66093762 |
| 67 | RIPK1 | 0.64786329 |
| 68 | DYRK1B | 0.58994184 |
| 69 | MAPK11 | 0.58814477 |
| 70 | CSK | 0.58058308 |
| 71 | PRPF4B | 0.57849630 |
| 72 | CDC42BPA | 0.56732402 |
| 73 | ERBB2 | 0.55143219 |
| 74 | LIMK1 | 0.50449432 |
| 75 | IRAK1 | 0.48053954 |
| 76 | PAK2 | 0.46900711 |
| 77 | PDK3 | 0.45965310 |
| 78 | PDK4 | 0.45965310 |
| 79 | TBK1 | 0.45465871 |
| 80 | MAP3K6 | 0.45060965 |
| 81 | PDPK1 | 0.43614834 |
| 82 | WNK4 | 0.42116505 |
| 83 | PRKCQ | 0.41870536 |
| 84 | CAMKK1 | 0.41323402 |
| 85 | RIPK4 | 0.40307516 |
| 86 | STK10 | 0.40148712 |
| 87 | CDK19 | 0.38749170 |
| 88 | MAPKAPK2 | 0.38376302 |
| 89 | PAK1 | 0.38366492 |
| 90 | PIM1 | 0.38326494 |
| 91 | CSNK1A1 | 0.38180828 |
| 92 | PDK2 | 0.37749485 |
| 93 | BMPR2 | 0.36898703 |
| 94 | INSRR | 0.36739586 |
| 95 | AKT3 | 0.36179180 |
| 96 | CAMK1 | 0.36020489 |
| 97 | PRKCA | 0.35964921 |
| 98 | DAPK3 | 0.34783219 |
| 99 | RET | 0.33538205 |
| 100 | ZAP70 | 0.33279918 |
| 101 | MAPK15 | 0.32496238 |
| 102 | JAK2 | 0.31896544 |
| 103 | ADRBK2 | 0.31320476 |
| 104 | ITK | 0.31273100 |
| 105 | MATK | 0.31211271 |
| 106 | JAK1 | 0.30965535 |
| 107 | PDK1 | 0.30845854 |
| 108 | SRC | 0.30394168 |
| 109 | FYN | 0.30334752 |
| 110 | MAP4K1 | 0.29914266 |
| 111 | PAK3 | 0.29607581 |
| 112 | STK39 | 0.27760934 |
| 113 | PRKAA2 | 0.27355274 |
| 114 | YES1 | 0.27079130 |
| 115 | EIF2AK3 | 0.26438995 |
| 116 | TAOK2 | 0.26010207 |
| 117 | IKBKE | 0.25898822 |
| 118 | CAMK2A | 0.24404478 |
| 119 | DAPK2 | 0.23201971 |
| 120 | PRKCZ | 0.23051456 |
| 121 | LYN | 0.22664347 |
| 122 | NEK6 | 0.22147185 |
| 123 | PRKCE | 0.21929046 |
| 124 | MAP2K3 | 0.21815043 |
| 125 | PRKCD | 0.20443849 |
| 126 | BCR | 0.20267426 |
| 127 | IGF1R | 0.19894511 |
| 128 | KDR | 0.19329376 |
| 129 | DDR2 | 0.18843364 |
| 130 | GRK1 | 0.18628557 |
| 131 | CSNK1G3 | 0.17812141 |
| 132 | BMX | 0.17739692 |
| 133 | PIK3CG | 0.17632595 |
| 134 | PRKCB | 0.17071860 |
| 135 | MAP3K14 | 0.16612312 |
| 136 | DMPK | 0.16351631 |
| 137 | RPS6KA2 | 0.14501457 |
| 138 | PRKACA | 0.14376765 |
| 139 | MAPK7 | 0.11380454 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 5.73927941 |
| 2 | Pancreatic secretion_Homo sapiens_hsa04972 | 3.64243865 |
| 3 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.44211172 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.29877164 |
| 5 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 3.13649667 |
| 6 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.05278630 |
| 7 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.00628666 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.71185794 |
| 9 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.49427243 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.47093490 |
| 11 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.25738865 |
| 12 | Retinol metabolism_Homo sapiens_hsa00830 | 1.99308920 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93049848 |
| 14 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.92571394 |
| 15 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.86593315 |
| 16 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.76650800 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.74361036 |
| 18 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.71423677 |
| 19 | Mineral absorption_Homo sapiens_hsa04978 | 1.64382229 |
| 20 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.62153096 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.60534564 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.59763884 |
| 23 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.57233630 |
| 24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.53522724 |
| 25 | Galactose metabolism_Homo sapiens_hsa00052 | 1.52291459 |
| 26 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.52010678 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.51408708 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.47703439 |
| 29 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.45266049 |
| 30 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.45101800 |
| 31 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.44942480 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.43323567 |
| 33 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.40530144 |
| 34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.33674716 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.31922339 |
| 36 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.19808840 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.19114993 |
| 38 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.19094038 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.16574236 |
| 40 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.16059980 |
| 41 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.14827961 |
| 42 | Parkinsons disease_Homo sapiens_hsa05012 | 1.14537435 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.06998985 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03228979 |
| 45 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.00889890 |
| 46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.99660607 |
| 47 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.97831507 |
| 48 | Protein export_Homo sapiens_hsa03060 | 0.97051274 |
| 49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.95598054 |
| 50 | Alzheimers disease_Homo sapiens_hsa05010 | 0.93457664 |
| 51 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.89723510 |
| 52 | Asthma_Homo sapiens_hsa05310 | 0.88332865 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87735106 |
| 54 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.84559565 |
| 55 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82020815 |
| 56 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.81976894 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 0.78116662 |
| 58 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.77744073 |
| 59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76956138 |
| 60 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72572023 |
| 61 | Tight junction_Homo sapiens_hsa04530 | 0.72514063 |
| 62 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.72280093 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.70617052 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.70116451 |
| 65 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69142674 |
| 66 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.68268604 |
| 67 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.68141931 |
| 68 | Allograft rejection_Homo sapiens_hsa05330 | 0.63519401 |
| 69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.59287557 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.59000999 |
| 71 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.58061810 |
| 72 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.56907082 |
| 73 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55884925 |
| 74 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54079640 |
| 75 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.53274645 |
| 76 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50861176 |
| 77 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.48875419 |
| 78 | Huntingtons disease_Homo sapiens_hsa05016 | 0.48370947 |
| 79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46525535 |
| 80 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.45674461 |
| 81 | Insulin secretion_Homo sapiens_hsa04911 | 0.43964767 |
| 82 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.43881859 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43312043 |
| 84 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.42342873 |
| 85 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.41576704 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39962905 |
| 87 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.38825548 |
| 88 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.38596527 |
| 89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38328109 |
| 90 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35790509 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.33389321 |
| 92 | Thyroid cancer_Homo sapiens_hsa05216 | 0.32615804 |
| 93 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.27687433 |
| 94 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.26885509 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.25383610 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | 0.24883480 |
| 97 | Influenza A_Homo sapiens_hsa05164 | 0.24775792 |
| 98 | Peroxisome_Homo sapiens_hsa04146 | 0.21941779 |
| 99 | ABC transporters_Homo sapiens_hsa02010 | 0.21616312 |
| 100 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.21228287 |
| 101 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.20396914 |
| 102 | Salmonella infection_Homo sapiens_hsa05132 | 0.19614645 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19433713 |
| 104 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.18729341 |
| 105 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.18119202 |
| 106 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.16586166 |
| 107 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.16272958 |
| 108 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.16078406 |
| 109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.15581893 |
| 110 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.13375909 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.11953760 |
| 112 | Renin secretion_Homo sapiens_hsa04924 | 0.11349453 |
| 113 | Pertussis_Homo sapiens_hsa05133 | 0.10401858 |
| 114 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.10032226 |
| 115 | Leishmaniasis_Homo sapiens_hsa05140 | 0.07841111 |
| 116 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.07757554 |
| 117 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.07567912 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.07136412 |
| 119 | Other glycan degradation_Homo sapiens_hsa00511 | 0.04827446 |
| 120 | Amoebiasis_Homo sapiens_hsa05146 | 0.04477552 |
| 121 | Cocaine addiction_Homo sapiens_hsa05030 | 0.04161753 |
| 122 | Salivary secretion_Homo sapiens_hsa04970 | 0.03165714 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.02932911 |
| 124 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.01256580 |
| 125 | Viral myocarditis_Homo sapiens_hsa05416 | -0.0320468 |
| 126 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.0317578 |
| 127 | Complement and coagulation cascades_Homo sapiens_hsa04610 | -0.0117142 |
| 128 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | -0.0110108 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0069282 |
| 130 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | -0.0044721 |

